Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 66320

1.

CD127 Expression, Exhaustion Status and Antigen Specific Proliferation Predict Sustained Virologic Response to IFN in HCV/HIV Co-Infected Individuals.

Kared H, Saeed S, Klein MB, Shoukry NH.

PLoS One. 2014 Jul 9;9(7):e101441. doi: 10.1371/journal.pone.0101441. eCollection 2014.

PMID:
25007250
[PubMed - as supplied by publisher]
Free Article
2.

Predictors of Mortality among United States Veterans with Human Immunodeficiency Virus and Hepatitis C Virus Coinfection.

Erqou S, Mohanty A, Murtaza Kasi P, Butt AA.

ISRN Gastroenterol. 2014 Apr 7;2014:764540. doi: 10.1155/2014/764540. eCollection 2014.

PMID:
25006471
[PubMed]
Free Article
3.

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients.

Beisel C, Heuer M, Otto B, Jochum J, Schmiedel S, Hertling S, Degen O, Lüth S, van Lunzen J, Schulze Zur Wiesch J.

AIDS Res Ther. 2014 Jul 1;11:16. doi: 10.1186/1742-6405-11-16. eCollection 2014.

PMID:
25006340
[PubMed]
Free Article
4.

Prevalence of vitamin D deficiency and insufficiency in Bulgarian patients with chronic Hepatitis C viral infection.

Gerova DI, Galunska BT, Ivanova II, Kotzev IA, Tchervenkov TG, Balev SP, Svinarov DA.

Scand J Clin Lab Invest. 2014 Jul 9:1-8. [Epub ahead of print]

PMID:
25005344
[PubMed - as supplied by publisher]
5.

ABT-450: A Novel Protease Inhibitor For the Treatment of Hepatitis C Virus Infection.

Gentile I, Borgia F, Buonomo AR, Zappulo E, Castaldo G, Borgia G.

Curr Med Chem. 2014 Jul 6. [Epub ahead of print]

PMID:
25005190
[PubMed - as supplied by publisher]
6.

Anti-Hepatitis C Virus Activity of Crude Extract and Fractions of Entada africana in Genotype 1b Replicon Systems.

Galani Tietcheu BR, Sass G, Njayou NF, Mkounga P, Tiegs G, Moundipa PF.

Am J Chin Med. 2014;42(4):853-68. doi: 10.1142/S0192415X14500542.

PMID:
25004879
[PubMed - in process]
7.

Validation of Non-invasive Methods for Detecting Hepatic Steatosis in Patients with HIV Infection.

Siddiqui MS, Patidar KR, Boyett S, Smith PG, Sanyal AJ, Sterling RK.

Clin Gastroenterol Hepatol. 2014 Jul 5. pii: S1542-3565(14)00975-6. doi: 10.1016/j.cgh.2014.06.027. [Epub ahead of print]

PMID:
25004459
[PubMed - as supplied by publisher]
8.

Trace amounts of sporadically reappearing HCV RNA can cause infection.

Veerapu NS, Park SH, Tully DC, Allen TM, Rehermann B.

J Clin Invest. 2014 Jul 8. pii: 73104. doi: 10.1172/JCI73104. [Epub ahead of print]

PMID:
25003189
[PubMed - as supplied by publisher]
9.

A cognitive computational model inspired by the immune system response.

Abdo Abd Al-Hady M, Badr AA, Mostafa MA.

Biomed Res Int. 2014;2014:852181. doi: 10.1155/2014/852181. Epub 2014 Jun 9.

PMID:
25003131
[PubMed - in process]
Free PMC Article
10.

Quality of life in patients with thalassemia major.

Ansari Sh, Baghersalimi A, Azarkeivan A, Nojomi M, Hassanzadeh Rad A.

Iran J Ped Hematol Oncol. 2014;4(2):57-63. Epub 2014 Apr 20.

PMID:
25002926
[PubMed]
Free PMC Article
11.

Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers.

Javadi A, Ataei B, Kassaian N, Nokhodian Z, Yaran M.

J Res Med Sci. 2014 Mar;19(Suppl 1):S17-21.

PMID:
25002888
[PubMed]
Free PMC Article
12.

Statin efficacy in the treatment of hepatitis C genotype I.

Shavakhi A, Minakari M, Bighamian A, Sadeghian S, Shavakhi S, Khamisi N, Khodadustan M, Talebi M, Ataei B.

J Res Med Sci. 2014 Mar;19(Suppl 1):S1-4.

PMID:
25002886
[PubMed]
Free PMC Article
13.

In silico studies of medicinal compounds against hepatitis C capsid protein from north India.

Mathew S, Faheem M, Archunan G, Ilyas M, Begum N, Jahangir S, Qadri I, Qahtani MA, Mathew S.

Bioinform Biol Insights. 2014 Jun 23;8:159-68. doi: 10.4137/BBI.S15211. eCollection 2014.

PMID:
25002815
[PubMed]
Free PMC Article
14.

Sofosbuvir for the treatment of hepatitis C virus infection.

Rolland S, Vachon ML.

CMAJ. 2014 Jul 7. pii: cmaj.140151. [Epub ahead of print] No abstract available.

PMID:
25002563
[PubMed - as supplied by publisher]
15.

Discrete conformations of epitope II on the hepatitis C virus E2 protein for antibody-mediated neutralization and nonneutralization.

Deng L, Ma L, Virata-Theimer ML, Zhong L, Yan H, Zhao Z, Struble E, Feinstone S, Alter H, Zhang P.

Proc Natl Acad Sci U S A. 2014 Jul 7. pii: 201411317. [Epub ahead of print]

PMID:
25002515
[PubMed - as supplied by publisher]
Free Article
16.

Antiviral treatment of hepatitis C.

Feeney ER, Chung RT.

BMJ. 2014 Jul 7;349:g3308. doi: 10.1136/bmj.g3308. Review.

PMID:
25002352
[PubMed - as supplied by publisher]
Free Article
17.

You're Not the One: Treating Subjects Co-infected with Hepatitis C Genotypes 2 and 3 and Human Immunodeficiency Virus.

Pearlman BL, Lim TH.

Dig Dis Sci. 2014 Jul 8. [Epub ahead of print] No abstract available.

PMID:
25002310
[PubMed - as supplied by publisher]
18.

[Economic sustainability of therapies: considerations following the introduction of new drugs for hepatitis C virus].

Spandonaro F.

Recenti Prog Med. 2014 Jun;105(6):0. doi: 10.1701/1543.16849. Italian.

PMID:
25002289
[PubMed - in process]
19.

[Hepatitis C therapy: a problem almost solved].

Rizzetto M.

Recenti Prog Med. 2014 Jun;105(6):225-6. doi: 10.1701/1543.16847. Italian.

PMID:
25002283
[PubMed - in process]
20.

Innate immune cell networking in hepatitis C virus infection.

Saha B, Szabo G.

J Leukoc Biol. 2014 Jul 7. pii: jlb.4MR0314-141R. [Epub ahead of print] Review.

PMID:
25001860
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk